Target Name: PAPOLA
NCBI ID: G10914
Other Name(s): PAP | polynucleotide adenylyltransferase alpha | Polynucleotide adenylyltransferase alpha | Poly(A) polymerase alpha | Poly(A) polymerase alpha (isoform 1) | PAPOA_HUMAN | PAP-alpha | Poly(A) polymerase alpha, transcript variant 1 | poly(A) polymerase alpha | MGC5378 | PAPOLA variant 1

PAP as A Drug Target and Biomarker

Papolactone (PAP) is a protein produced by the mammalian papillae, which are found in the skin and other mucous membranes. PAP is known for its unique structure, which consists of a long extracellular domain and a short intracellular tail. This structure allows PAP to interact with various cell types and molecules, making it a potential drug target and biomarker.

Drug Target Potential

PAP has been identified as a potential drug target due to its unique structure and various cellular interactions. One of the main reasons for its potential as a drug is its ability to interact with various cell types, including cancer cells, neurons, and immune cells. This interaction allows PAP to play a role in the development and progression of various diseases.

For example, PAP has been shown to promote the growth and survival of cancer cells. This has led to the development of PAP-targeted drugs that can inhibit its activity, such as the anti-cancer drug, IPT-182. Additionally, PAP has also been shown to interact with neurons, which can lead to its potential as a neurodegenerative drug target.

Biomarker Potential

PAP has also been identified as a potential biomarker for various diseases. Its unique structure and interactions with various cell types make it a potential indicator of disease. For example, PAP has been shown to be involved in the development and progression of skin cancer, which makes it a potential biomarker for this disease.

Additionally, PAP has also been shown to be involved in the development and progression of other diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases. This makes it a potential biomarker for these diseases as well.

Conclusion

PAP is a protein produced by the mammalian papillae that has been identified as a potential drug target and biomarker. Its unique structure and interactions with various cell types make it a potential target for the development of new drugs. Additionally, its potential as a biomarker for various diseases makes it an attractive candidate for diagnostic tools. Further research is needed to fully understand the role of PAP in disease and its potential as a drug and biomarker.

Protein Name: Poly(A) Polymerase Alpha

Functions: Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus

More Common Targets

PAPOLA-DT | PAPOLB | PAPOLG | PAPPA | PAPPA-AS1 | PAPPA-AS2 | PAPPA2 | PAPSS1 | PAPSS2 | PAQR3 | PAQR4 | PAQR5 | PAQR6 | PAQR7 | PAQR8 | PAQR9 | PAR Receptor | PAR-3-PAR-6B-PRKCI complex | Parathyroid Hormone Receptors (PTHR) | PARD3 | PARD3B | PARD6A | PARD6B | PARD6G | PARD6G-AS1 | PARG | PARGP1 | PARK7 | PARL | PARM1 | PARM1-AS1 | PARN | PARP1 | PARP10 | PARP11 | PARP12 | PARP14 | PARP15 | PARP16 | PARP2 | PARP3 | PARP4 | PARP6 | PARP8 | PARP9 | PARPBP | PARS2 | PART1 | PARTICL | PARVA | PARVB | PARVG | Parvovirus initiator complex | PASD1 | PASK | Patatin-like phospholipase domain-containing protein | PATE1 | PATE2 | PATE3 | PATE4 | PATJ | PATL1 | PATL2 | PATZ1 | PAUPAR | PAWR | PAX1 | PAX2 | PAX3 | PAX4 | PAX5 | PAX6 | PAX6-AS1 | PAX7 | PAX8 | PAX8-AS1 | PAX9 | PAXBP1 | PAXBP1-AS1 | PAXIP1 | PAXIP1-AS2 | PAXIP1-DT | PAXX | PBDC1 | PBK | PBLD | PBOV1 | PBRM1 | PBX1 | PBX2 | PBX3 | PBX3-DT | PBX4 | PBXIP1 | PC | PCA3 | PCAF complex | PCARE | PCAT1 | PCAT14